BioInvent, Human Genome in mAb deal

BioInvent International AB (SSE:BINV) and Human Genome Sciences Inc. (NASDAQ:HGSI) partnered to discover, develop and commercialize mAbs against antigens discovered by Human Genome, with an initial fo...